Implantable drug shows promise for weight control in early trial
NCT ID NCT05670379
First seen Nov 01, 2025 · Last updated Apr 29, 2026 · Updated 30 times
Summary
This early-stage study tested the safety and drug levels of an exenatide implant placed under the skin in 24 overweight or obese adults without diabetes. The implant slowly releases medication to help control appetite and blood sugar. The study focused on how the body processes the drug and any side effects, not on weight loss itself.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERWEIGHT AND OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CMax
Adelaide, Australia
Conditions
Explore the condition pages connected to this study.